We identified four new independent, unrelated POLE Leu424Val heterozygotes, two from the CORGI study (Fig. 2 Families M and N, Supplementary Table S3) and two, diagnosed with CRC at ages 46 and 37, in the QUASAR 2 trial (Supplementary Table S3). This evidence concerns the gene POLE and colorectal carcinoma.